Protara Therapeutics, Inc.
TARA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $163 | $40 | $24 | $36 |
| Short-Term Investments | $7 | $26 | $60 | $56 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $1 | $0 |
| Other Curr. Assets | $2 | $3 | $0 | $1 |
| Total Curr. Assets | $172 | $69 | $86 | $93 |
| Property Plant & Equip (Net) | $5 | $7 | $8 | $9 |
| Goodwill | $0 | $0 | $0 | $30 |
| Intangibles | $3 | $3 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $18 | $39 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $2 |
| Total NC Assets | $9 | $10 | $27 | $79 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $181 | $79 | $113 | $173 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $2 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $3 | $3 | $2 |
| Total Curr. Liab. | $11 | $6 | $6 | $4 |
| LT Debt | $3 | $4 | $5 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $4 | $5 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $6 | $7 |
| Total Liabilities | $14 | $11 | $11 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$245 | -$200 | -$160 | -$94 |
| AOCI | $0 | -$0 | -$1 | -$0 |
| Other Equity | $412 | $269 | $263 | $256 |
| Total Equity | $167 | $68 | $102 | $162 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $181 | $79 | $113 | $173 |
| Net Debt | -$158 | -$34 | -$18 | -$28 |